Radiopharmaceuticals, Imaging Agents
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
72
NCT06021626
A Study of CRD3874-SI in People With Solid Tumors
Phase: Phase 1
Role: Collaborator
Start: Aug 25, 2023
Completion: Aug 31, 2029
Loading map...